Issue: FDA and Drug Regulation
     
 
En Español

The Power of Independent Thinking

←  ISSUES
Issues
›
Regulation
›
FDA and Drug Regulation
›
Commentary

Showing 11 - 20 of 197 Results.

What to Do about Our Biggest Health Care Problems
John C. Goodman | Commentary | Mar. 1, 2024
The Biden Administration versus Medicare Advantage
John C. Goodman | Commentary | Feb. 21, 2024
The Bitter Truth Behind Sugary Soda Taxes
William F. Shughart II, Josh T. Smith | Commentary | Feb. 21, 2024
Travis Kelce, COVID ‘Variants,’ and the CDC Vaccine Machine
K. Lloyd Billingsley | Commentary | Jan. 22, 2024
Can We Reduce Health Care Costs with Better Primary Care?
John C. Goodman | Commentary | Jan. 2, 2024
Political Promises Won’t End Drug Shortages
Raymond J. March | Commentary | Dec. 21, 2023
Randi Weingarten Lies, Lies and Lies Again about Closing Schools During COVID
Corey DeAngelis | Commentary | Dec. 6, 2023
The Epistle of Paul to the Americans: Exposing White Coat Supremacy
The perfect Christmas gift for Congress.
K. Lloyd Billingsley | Commentary | Nov. 30, 2023
Psychedelics Will Help America’s Mental Health Crisis—If the FDA Lets Them
Raymond J. March | Commentary | Nov. 10, 2023
Markets Can Help Fix the Blood Shortage
Raymond J. March | Commentary | Nov. 4, 2023






  • Catalyst
  • Beyond Homeless
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org
© 2024 INDEPENDENT INSTITUTE, 100 SWAN WAY, OAKLAND CA 94621‑1428 | (510) 632‑1366 | (510) 568‑6040 FAX | SEND EMAIL